Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion.
about
Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Preclinical pharmacology of AZ ...... ects on electrolyte excretion.
@en
Preclinical pharmacology of AZ ...... ects on electrolyte excretion.
@nl
type
label
Preclinical pharmacology of AZ ...... ects on electrolyte excretion.
@en
Preclinical pharmacology of AZ ...... ects on electrolyte excretion.
@nl
prefLabel
Preclinical pharmacology of AZ ...... ects on electrolyte excretion.
@en
Preclinical pharmacology of AZ ...... ects on electrolyte excretion.
@nl
P2093
P2860
P50
P1433
P1476
Preclinical pharmacology of AZ ...... fects on electrolyte excretion
@en
P2093
Anders Gunnarsson
Anna Aagaard
Anna Björnson Granqvist
Judith Hartleib-Geschwindner
Karl Edman
Kenneth L Granberg
Lena William-Olsson
Stefan Geschwindner
Susanna Myhre
Ulrika Johansson
P2860
P304
P356
10.1371/JOURNAL.PONE.0193380
P407
P577
2018-02-23T00:00:00Z